Results of a clinical study of the efficacy and safety of Panavir® in the therapy of post-primary herpetic keratitis

Objective: to analyze the efficacy, safety and tolerability of Panavir® (eye drops 0.004%) in the complex therapy of post-primary herpetic keratitis. Material and methods. 106 patients with post-primary herpetic keratitis participated. Patients in group 1 received Panavir® in combination with acyclovir (eye ointment 3%), patients in group 2 - placebo and acyclovir (eye ointment 3%). The study included 6 visits. Results. Complete epithelialization of the cornea at visits 3 and 4 was registered in significantly (p